1 |
霍家康, 郭欣, 戴婉薇, 等. 我国康复需求与科研供给关系的回顾性研究 [J]. 中国科学:生命科学, 2023, 53(9): 1287-1297.
|
2 |
王一然, 戴婉薇, 苏彬彬, 等. 我国康复服务需求评估与供需缺口原因分析 [J]. 中国康复理论与实践, 2022, 28(6): 725-729.
|
3 |
Phan P, Mitragotri S, Zhao Z. Digital therapeutics in the clinic [J].Bioeng Transl Med, 2023, 8(4): e10536.
|
4 |
Hong JS, Wasden C, Han DH. Introduction of digital therapeutics [J].Comput Methods Programs Biomed, 2021, 209: 106319.
|
5 |
Son S, Yoo BR, Jeong YM. Digital therapeutics-based lumbar core exercise for patients with low back pain: A prospective exploratory pilot study [J]. Digit Health, 2024, 10: 20552076231218154.
|
6 |
Orsolini L, Longo G, Volpe U. Practical application of digital therapeutics in people with mood disorders [J]. Curr Opin Psychiatry,2024, 37(1): 9-17.
|
7 |
Kario K, Nomura A, Harada N, et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial [J]. Eur Heart J, 2021, 42(40): 4111-4122.
|
8 |
Saleh ZM, Chey WD, Berry SK. Behavioral health digital therapeutics for patients with irritable bowel syndrome: a primer for gastroenterologists [J]. Am J Gastroenterol, 2023, 118(8): 1311-1313.
|
9 |
Rumi G, Canonica GW, Foster JM, et al. Digital coaching using smart inhaler technology to improve asthma management in patients with asthma in Italy: community-based study [J]. JMIR Mhealth Uhealth,2022, 10(11): e25879.
|
10 |
Fundoiano-Hershcovitz Y, Feniger E, Dar S, et al. Digital therapeutics for type 2 diabetes: incorporating coaching support and validating digital monitoring [J]. J Diabetes Sci Technol, 2021, 15(5): 1188-1189.
|
11 |
Rohaj A, Bulaj G. Digital Therapeutics (DTx) expand multimodal treatment options for chronic low back pain: the nexus of precision medicine, patient education, and public health [J]. Healthcare (Basel),2023, 11(10): 1469.
|
12 |
Correia FD, Molinos M, Luís S, et al. Digitally assisted versus conventional home-based rehabilitation after arthroscopic rotator cuffrepair: a randomized controlled trial [J]. Am J Phys Med Rehabil,2022, 101(3): 237-249.
|
13 |
Shah N, Costello K, Mehta A, et al. Applications of digital health technologies in knee osteoarthritis: narrative review [J]. JMIR Rehabil Assist Technol, 2022, 9(2): e33489.
|
14 |
Rassi-Cruz M, Valente F, Caniza MV. Digital therapeutics and the need for regulation: how to develop products that are innovative, patientcentric and safe [J]. Diabetol Metab Syndr, 2022, 14(1): 48.
|
15 |
刘芳明, 石秀秀, 唐冲, 等. 骨科康复患者对数字疗法应用的知晓度和需求度:一项基于928 份问卷调查结果分析 [J/OL]. 中华临床医师杂志(电子版), 2024, 18(7): 654-661.
|
16 |
Brezing CA, Brixner DI. The rise of prescription digital therapeutics in behavioral health [J]. Adv Ther, 2022, 39(12): 5301-5306.
|
17 |
Budney AJ, Marsch LA, Aklin WM, et al. Workshop on the development and evaluation of digital therapeutics for health behavior change: science, methods, and projects [J]. JMIR Ment Health, 2020,7(2): e16751.
|
18 |
Basch E. Digital therapeutics for remote symptom monitoring and management in cancer care: the current and future state [J]. Ann Oncol, 2023, 34(8): 635-637.
|
19 |
Bickenbach J, Sabariego C, Stucki G. Beneficiaries of rehabilitation [J].Arch Phys Med Rehabil, 2021, 102(3): 543-548.
|
20 |
Bates B. Doctor and nurse: changing roles and relations [J]. N Engl J Med, 1970, 283(3): 129-134.
|
21 |
Liu J, Liu S, Zheng T, et al. Physicians' perspectives of telemedicine during the COVID-19 pandemic in China: qualitative survey study [J].JMIR Med Inform, 2021, 9(6): e26463.
|
22 |
Li Y, Gong Y, Zheng B, et al. Effects on adherence to a mobile appbased self-management digital therapeutics among patients with coronary heart disease: pilot randomized controlled trial [J]. JMIR Mhealth Uhealth, 2022, 10(2): e32251.
|
23 |
Kollins SH, DeLoss DJ, Cañadas E, et al. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD):a randomised controlled trial [J]. Lancet Digit Health, 2020, 2(4):e168-e178.
|
24 |
Nomura A, Tanigawa T, Kario K, et al. Cost-effectiveness of digital therapeutics for essential hypertension [J]. Hypertens Res, 2022,45(10): 1538-1548.
|
25 |
Müthing J, Jäschke T, Friedrich CM. Client-focused security assessment of mHealth apps and recommended practices to prevent or mitigate transport security issues [J]. JMIR Mhealth Uhealth, 2017,5(10): e147.
|
26 |
Schnall R, Higgins T, Brown W, et al. Trust, perceived risk, perceived ease of use and perceived usefulness as factors related to mHealth technology use [J]. Stud Health Technol Inform, 2015, 216: 467-471.
|
27 |
Larentzakis A, Lygeros N. Artificial intelligence (AI) in medicine as a strategic valuable tool [J]. Pan Afr Med J, 2021, 38: 184.
|
28 |
Mueller FB. AI (Artificial Intelligence) and hypertension research [J].Curr Hypertens Rep, 2020, 22(9): 70.
|
29 |
He J, Baxter SL, Xu J, et al. The practical implementation of artificial intelligence technologies in medicine [J]. Nat Med, 2019, 25(1): 30-36.
|
30 |
Nadarzynski T, Miles O, Cowie A, et al. Acceptability of artificial intelligence (AI)-led chatbot services in healthcare: A mixed-methods study [J]. Digit Health, 2019, 5: 2055207619871808.
|
31 |
Maadi M, Akbarzadeh Khorshidi H, Aickelin U. A review on human-AI interaction in machine learning and insights for medical applications [J]. Int J Environ Res Public Health, 2021, 18(4): 2121.
|
32 |
Palanica A, Flaschner P, Thommandram A, et al. Physicians'perceptions of chatbots in health care: cross-sectional web-based survey [J]. J Med Internet Res, 2019, 21(4): e12887.
|
33 |
De Rosis S, Barsanti S. Patient satisfaction, e-health and the evolution of the patient-general practitioner relationship: evidence from an Italian survey [J]. Health Policy, 2016, 120(11): 1279-1292.
|